Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-29

Clinical Trial Update: Observation of Treatment With Certolizumab Pegol in Daily Practice

View source ↗

Summary

This document summarizes results from an observational study of certolizumab pegol used in daily practice for rheumatoid arthritis. Results from the study were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: UCB Pharma GmbH | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2015-09-29